Background and aims: Dyspnoea-12 assesses dyspnea based on the physical and affective components of the symptom. The aim of this study was to translate the Dyspnoea-12 into Portuguese, and to obtain validation data regarding the use of this tool in patients with chronic obstructive lung disease (COPD).
| IN TRO DUCT IO N
Dyspnea is a subjective experience and one of the most relevant factors affecting quality of life in patients with chronic lung diseases. [1] [2] [3] [4] [5] Besides reflecting respiratory distress, clinical dyspnea measurements also provide prognostic value, both in patients with obstructive and restrictive respiratory impairments. 6, 7 Despite recent advances in knowledge about respiratory sensations, the mechanisms involved in dyspnea pathogenesis are not fully understood. 8 Evidence has been building over the years indicating that the word dyspnea is employed by patients to describe more than one unpleasant respiratory sensation. 9, 10 In addition, such sensations may trigger secondary psychological, behavioral and social responses, which eventually become an integral part of the respiratory symptom itself. 1, 2 Traditional dyspnea scales may grade the intensity of breathlessness induced by an effort in a precise moment, for example, the application of Borg scale at the end of a maximal exercise test. In alternative scenarios, dyspnea scales investigate the amount of physical effort usually associated with its emergence as, for example, the Medical Research Council scale (MRC). 11 An innovative approach was recently proposed for measuring dyspnea, consisting of a measure developed from the language used by patients to describe the physical and affective responses to the experience of breathlessness. The measurement tool is called During the development of Dyspnoea-12 Yorke et al determined the 12 most relevant dyspnea descriptors from a comprehensive list of expressions applied to patients with chronic pulmonary obstructive disease (COPD), interstitial lung disease and heart failure. 12 These descriptors cover a physical component, composed of seven items, and an affective element characterized by another five.
The new scale showed significant correlations with scores of anxiety and depression, degrees of dyspnea measured using the MRC scale, forced expiratory volume in the first second (FEV 1 ), and Six Minute Walk Test (6mWT) distance in a group of 53 COPD patients. Further studies yielded elements of instrument validity also in asthma, interstitial lung diseases and pulmonary hypertension. [13] [14] [15] The Dyspnoea-12 scale has also been translated to other languages and its use is validated in non-English speaking subjects including Arabic and Korean. 16, 17 The present study aimed at translating and adapting the Dyspnoea-12 scale from English to the Portuguese language. Along with the translated version of the scale, results of its validation in patients with COPD are also shown.
| MAT ERI AL S A ND M ETH ODS

| Subjects
The study was conducted in the Hospital das Clínicas de Ribeirão Preto, a major university hospital in Brazil. Conduct of this study was in accordance with the ethical standards of the Helsinki Declaration of 1975, as revised in 2000, and was approved by the Institutional Review Board of the Hospital das Clínicas de Ribeirão Preto. All volunteers signed informed consent forms before being enrolled into the study.
Patients with COPD of both genders were sequentially selected from the outpatient service. All of them were in stable clinical conditions for at least two months as determined from by their regular outpatient follow-up visits. The diagnosis of COPD was established based on criteria recommended by the Global Initiative of Chronic Obstructive Lung Disease (GOLD).
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The study excluded illiterate patients, people with visual or hearing impairments, severe co-morbidities or those whose primary language was not Portuguese.
| Translation and transcultural adaptation
The initial phase of the study involved translation and adaptation of the Dyspnoea-12 scale from its original version in British English into Portuguese as spoken in Brazil, according to classical methodology. 19 In brief, the original scale was translated by three Brazilian pulmonologists with experience in the care of COPD patients, and who had also lived for long periods in English-speaking countries. The three versions were then evaluated by a multidisciplinary group composed of two pulmonologists and a physiotherapist who came to a consensus preliminary translation. This version underwent back-translation to English by two American citizens, residents in Brazil for years, and familiar with both languages. The back-translation was assessed by the multidisciplinary group and, as it was found analogous to the original text, it was sent to the creator of the scale in England for review. Some minor suggested changes in the nomenclature used for grading the items were made and the working version was re-evaluated by the multidisciplinary group, resulting in a second draft in Portuguese.
The last version was then applied to 20 clinically stable COPD patients who had been regularly followed at the clinic and reported dyspnea chronically. They completed the translated dyspnea scale and answered some questions aimed at assessing the degree of understanding of the instrument. Since the degree of understanding by the 20 patients exceeded 90% for all items, this working version was chosen as definitive and named as Dyspnoea-12-Pt scale. This translated version was submitted to the subsequent validation processes.
| Validation studies
All COPD patients selected for this phase attended the pulmonary function laboratory and completed, in addition to the Dyspnoea-12-Pt scale, the following instruments: MRC dyspnea scale, Baseline Dyspnea Index (BDI), Saint George's Respiratory Questionnaire (SGRQ) and the Hospital Anxiety and Depression Scale. 11, [20] [21] [22] [23] The subjects then performed simple spirometry, before and after bronchodilator use, in a Koko spirometer (Nspire Health, Longmont, CO) according to technical recommendations of the Brazilian Thoracic Society. 24 Upon completion of spirometry, followed by a short rest, the volunteer subjects also completed a 6mWT in accordance with the American Thoracic Society guidelines. 25 The subjects performed two sequential 6mWT, with a 20 minutes interval between them. The test with the highest walked distance was chosen for analysis. All patients were instructed to return to the laboratory in 2 weeks to answer the Dyspnoea-12-Pt scale a second time.
The equations employed to calculate normal values for respiratory function parameters were those of Knudson and Crapo. 26 Equations used to calculate the expected value of the 6mWT were those of Soares and Pereira. 27 
| Statistical analysis
Results are shown as means and standard deviations. 
| RE S ULT S
The COPD group involved in the initial evaluation of the translated scale was composed of 15 men and 5 women, with a mean age of 68.0 6 5.2 years and a post-bronchodilator FEV 1 5 52.3% 6 6.1%. The original Dyspnoea-12 scale and its final translation and adaptation into Portuguese are displayed in Table 1 . The answers for each item ranged between 0 and 3 and the total score between 0 and 36. Fifty-one patients with COPD were included in the concurrent validation analysis of the Dyspnoea-12-Pt scale. Their clinical and functional features are summarized in Table 2 . The group was composed of 33 men and 18 women with a mean age of 66.4 6 8.1 years. The average postbronchodilator FEV 1 , for the group as a whole, was 48.7% 6 17.2% of the predicted. According to disease severity, the patients could be classified, according GOLD criteria, as: Class I: 4 (7.8%); Class II: 22 (43.2%); Class III: 18 (35.35) and Class IV: 7 (13.7%). Five patients refused to perform the 6mWT because of excessive dyspnea (2), orthopedic condition (1) or social reasons (2) .
There were significant correlations between the scores of Dyspnoea-12-Pt scale and the MRC, BDI and SGRQ values, as well as the rates of anxiety and depression (Table 3 and Figure 1) .
Linear regression models were built between BDI and SGRQ values and Dyspnoea-12-Pt scores as the dependent variables (Figures 2 and 3) . The value of the slope for the model including BDI was 21.932 (H 0 : slope 5 0, P < .0001) and the intercept was 26.696 (H 0 : intercept 5 36, P < .0001). The value of the slope for the model including the SGRQ was 0.464 (H 0 : slope 5 0, P < .0001) and the intercept was 210.686 (H 0 : intercept 5 0, P < .0001).
The scores using the Dyspnoea-12-Pt scale showed no significant correlations with the evaluated spirometric measurements. There were significant correlations between dyspnea scores and distances in the 6mWT, both expressed in Table 3) .
The Cronbach's alpha coefficient calculated for the answers of 51 COPD patients was 0.921. Forty-five COPD patients, always in stable clinical conditions, returned for a second interview in a mean time of 14.7 6 5.0 days. The intraclass correlation coefficient between Dyspnoea-12-Pt scores obtained on these two occasions was 0.829.
| DI S CUS S I ON
Dyspnea is a complex symptom influenced by physiological, sensory, environmental, and affective factors.
1,2 Several studies suggest that healthy people and patients use different expressions to describe that sensation and that these descriptors can be related to the generating mechanisms of the symptom. 9, 10 In this scenario, different dyspnea descriptors might be associated with specific clinical conditions.
1,2,28
The Dyspnoea-12 scale was developed in Great Britain and is the first measure of the symptom based exclusively on descriptors selected from a representative sample of patients. 12 The application of 81 previously reported descriptors to 358 dyspneic volunteers with chronic cardiorespiratory conditions resulted in the identification of 12 items, after a hierarchical elimination processes and application of a Rasch model. This solution comprises seven items of physical nature and five items of affective nature, and was subsequently validated for assessment of dyspneic patients in a number of situations such as COPD, interstitial lung disease and HP. The new dyspnea scale has gained increased acceptance, justifying its translation and adaptation into the Portuguese language.
The present version, translated into Portuguese spoken in Brazil, called Dyspnoea-12-Pt, proved to be easily understood by the patients interviewed, both in the early stages of the study, as well as throughout the formal validation process.
The observed values of Cronbach's alpha and the intraclass correlation coefficient for the group of COPD patients indicate excellent internal consistency and very satisfactory reproducibility test-retest of the translated version.
Correlations between scores of the Dyspnoea-12-Pt scale and the scales MRC, BDI, SGRQ and the measurements of Anxiety and Depression were significant, albeit in a modest degree. These correlations suggest the concurrent validity of the new scale in relation to previously published instruments of measuring dyspnea and quality of life. The small values of r obtained do not void this validation, since the Dyspnoea-12-Pt scale intends to measure the symptom from a totally distinct approach from the traditional instruments. Indeed, it is very meaningful that representative measurements of respiratory sensations and of secondary emotional responses do correlate with scores that reflect the intensity of workloads necessary to trigger such symptoms, such as the MRC scale.
Furthermore this is the first published study exploring possible associations between Dyspnoea-12 and BDI scores. Most relevant, the absolute value of this correlation was slightly higher than that observed employing the MRC scale. Initially, it is worth noting that higher BDI scores indicate less intense dyspnea. This latter scale was also designed to measure dyspnea under a distinct and original approach. 22 BDI consists of three subscales, namely: (1) functional impairment: assesses the loss or leaving of domestic duties or work; (2) magnitude of task: assesses the emergence of related dyspnea performing specific activities, such as carrying loads in the plan and (3) magnitude of effort: from a standardized activity, the dyspnea onset is associated with the intensity of the effort spent to its realization. All these three subscales showed significant correlations with Dispnoea-12-Pt scores. Interestingly, the best coefficient was observed between Dispnoea-12-Pt scores and the subscale magnitude of effort, a parameter dealing with the applied strength to perform physical activities. Despite its significance, the correlation between Dyspnoea-12-Pt and BDI appears to be imperfect as, at least in this sample, a few patients showed high scores of the first and simultaneous only moderate values of the last (Figure 2 ). In addition, Dypsnoea-12-Pt also appears to show a little less sensitivity to detect dyspnea than BDI. Regardless of these limitations, it is clear that the Dyspnoea-12-Pt scale reflects, to a substantial degree, another complex and multidimensional instrument of assessment of unpleasant respiratory sensations.
The best coefficient of correlation between scores of Dyspnoea-12-Pt and other subjective measures applied to COPD patients was with the total SGRQ. This finding is not entirely surprising, since the latter also includes evaluations of dyspnea and emotional manifestations associated with COPD. As a result we can assume that Dyspnoea-12-Pt reflects, in large part, changes in quality of life experienced by this group of patients. It is important to emphasize that, as may be seen in Figure 3 , in no case a zero score of Dyspnoea-12-Pt corresponds to none impairment on quality of life evaluated by the SGRQ. In this scenario, Dyspnoea-12-Pt is clearly less sensitive than SGRQ to detect such abnormalities. Finally, the significant correlations of Dyspnoea-12-Pt with Anxiety and Depression scores in COPD patients certainly reflect the incorporation in the first measure of five assessments of affective nature.
Contrasting with previous studies involving validation of other Dyspnoea-12 translations in COPD, no significant correlations were observed between spirometric measures and dyspnea scores of the present Portuguese version. 12, 16, 17 Significant correlations were not found even after performing additional analysis employing absolute values of parameters or using alternative formulas for calculations of normal predicted values (data not shown). This finding does not preclude the value of the present Portuguese version because, as already earlier stated, dyspnea is a complex symptom and is influenced by several factors, not only by the amount of respiratory functional impairment of the patients. 1, 2, 29 On the other hand, scores of Dyspnoea-12-Pt significantly correlated with walking distances of the 6mWT, expressed both as absolute values or as percentage of predicted. Certainly this last parameter better represents the overall physical capacity of patients with COPD, since it reflects not only their respiratory reserve, but also their cardiovascular and peripheral muscle conditions as well. Portuguese is listed as the sixth most natively spoken language in the world. There are about 260 million Portuguese native speakers in the world and the language frequently exhibits regional variations. Therefore, it is important to note that the scale Dyspnoea-12-Pt was translated and adapted from the English with Brazilian patients who use the form of the language spoken in Brazil. Despite this limitation, we believe it shows great potential for clinical application in all Portuguese speaking countries after eventual minor adjustments. In addition, the authors also believe that, although this Portuguese translation has been validated in COPD patients only, it meets standards to be also applied in the evaluation of Portuguese-speaking subjects with other cardiorespiratory disorders.
In conclusion, the Portuguese version of the Dyspnoea-12 scale (Dyspnoea-12-Pt) displays consistent bio and psychometric properties and may be reliably used in the evaluation of Portuguese-speaking patients with dyspnea due to COPD.
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